Processa Pharmaceuticals, Inc. (PCSA)
CIK 1533743 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Processa Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 18, 2026 | SCHEDULE 13G | 0001213900-26-091285 |
| Aug 14, 2026 | 10-Q | 0001493152-26-038334 |
| Aug 11, 2026 | 4 | 0000897069-26-001602 |
| Aug 4, 2026 | 8-K | 0001493152-26-036032 |
| Jul 30, 2026 | 3 | 0001575202-26-000009 |
| Jul 30, 2026 | 4 | 0001575202-26-000011 |
| Jul 29, 2026 | 8-K | 0001493152-26-035099 |
| Jul 28, 2026 | 4 | 0000897069-26-001554 |
| Jul 28, 2026 | 4 | 0000897069-26-001550 |
| Jul 28, 2026 | 4 | 0000897069-26-001552 |
| Jul 28, 2026 | 4 | 0000897069-26-001556 |
| Jul 28, 2026 | 4 | 0000897069-26-001548 |
| Jul 28, 2026 | 4 | 0000897069-26-001558 |
| Jul 28, 2026 | 4 | 0000897069-26-001560 |
| Jul 28, 2026 | 4 | 0000897069-26-001546 |
| Jul 1, 2026 | 4 | 0000897069-26-001478 |
| Jul 1, 2026 | 4 | 0000897069-26-001480 |
| Jul 1, 2026 | 4 | 0000897069-26-001484 |
| Jul 1, 2026 | 4 | 0000897069-26-001482 |
| Jul 1, 2026 | 4 | 0000897069-26-001476 |
| Jun 30, 2026 | 4 | 0000897069-26-001470 |
| Jun 30, 2026 | 4 | 0000897069-26-001472 |
| Jun 30, 2026 | 4 | 0000897069-26-001468 |
| Jun 30, 2026 | 4 | 0000897069-26-001466 |
| Jun 18, 2026 | DEF 14A | 0001493152-26-029326 |